发明授权
US09395354B2 Cardiomyocytes from induced pluripotent stem cells from patients and methods of use thereof
有权
来自患者的诱导性多能干细胞的心肌细胞及其使用方法
- 专利标题： Cardiomyocytes from induced pluripotent stem cells from patients and methods of use thereof
- 专利标题（中）： 来自患者的诱导性多能干细胞的心肌细胞及其使用方法
-
申请号： US13554946申请日： 2012-07-20
-
公开(公告)号： US09395354B2公开(公告)日： 2016-07-19
- 发明人: Ning Sun , Michael T. Longaker , Robert C. Robbins , Joseph Wu , Feng Lan , Andrew Stephen Lee , Paul W. Burridge
- 申请人： Ning Sun , Michael T. Longaker , Robert C. Robbins , Joseph Wu , Feng Lan , Andrew Stephen Lee , Paul W. Burridge
- 申请人地址： US CA Stanford
- 专利权人： The Board of Trustees of the Leland Stanford Junior University
- 当前专利权人： The Board of Trustees of the Leland Stanford Junior University
- 当前专利权人地址： US CA Stanford
- 代理机构： Bozicevic, Field & Francis LLP
- 代理商 Pamela J. Sherwood
- 主分类号： C12Q1/02
- IPC分类号： C12Q1/02 ; G01N27/49 ; G01N33/50 ; C12N5/077 ; C12N5/074
摘要：
Human somatic cells obtained from individuals with a genetic heart condition are reprogrammed to become induced pluripotent stem cells (iPS cells), and differentiated into cardiomyocytes for use in analysis, screening programs, and the like.